Trademark Overview
On Tuesday, April 9, 2019, a trademark application was filed for ADAR-RNA with the United States Patent and Trademark Office. The USPTO has given the ADAR-RNA trademark a serial number of 88377984. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Monday, January 6, 2020. This trademark is owned by EDIGENE INC. The ADAR-RNA trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:
Cell culture reagents for scientific and research use; Cells for scientific, laboratory or medical research; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic reagents for scientific use
Cells for medical or clinical use; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders, erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; Pharmaceutical preparations in the nature of genetically modified therapeutic pharmaceuticals, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations in the nature of biological tissue grafts; Diagnostic reagents for medicinal use
Medical and scientific research in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Medical and scientific research information in the field of genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics